Favel L Mondesir1, Todd M Brown2, Paul Muntner1, Raegan W Durant2, April P Carson1, Monika M Safford3, Emily B Levitan4. 1. Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL. 2. Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL. 3. Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL; General Internal Medicine, Weill Cornell Medicine, New York, NY. 4. Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL. Electronic address: elevitan@uab.edu.
Abstract
BACKGROUND: Evidence is mixed regarding whether diabetes confers equivalent risk of coronary heart disease (CHD) as prevalent CHD. We investigated whether diabetes and severe diabetes are CHD risk equivalents. METHODS: At baseline, participants in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study (black and white US adults ≥45 years old recruited in 2003-2007) were categorized as having prevalent CHD only (self-reported or electrocardiogram evidence; n = 3,043), diabetes only (self-reported or elevated glucose; n = 4,012), diabetes and prevalent CHD (n = 1,529), and neither diabetes nor prevalent CHD (n = 17,155). Participants with diabetes using insulin and/or with albuminuria (urinary albumin-to-creatinine ratio ≥30 mg/g) were categorized as having severe diabetes. Participants were followed up through 2011 for CHD events (myocardial infarction or fatal CHD). RESULTS: During a mean follow-up of 5 years, 1,385 CHD events occurred. The hazard ratios of CHD events comparing participants with diabetes only, diabetes, and prevalent CHD and neither diabetes nor prevalent CHD with those with prevalent CHD were 0.65 (95% CI 0.54-0.77), 1.54 (95% CI 1.30-1.83), and 0.41 (95% CI 0.35-0.47), respectively, after adjustment for demographics and risk factors. Compared with participants with prevalent CHD, the hazard ratio of CHD events for participants with severe diabetes was 0.88 (95% CI 0.72-1.09). CONCLUSIONS: Participants with diabetes had lower risk of CHD events than did those with prevalent CHD. However, participants with severe diabetes had similar risk to those with prevalent CHD. Diabetes severity may need consideration when deciding whether diabetes is a CHD risk equivalent.
BACKGROUND: Evidence is mixed regarding whether diabetes confers equivalent risk of coronary heart disease (CHD) as prevalent CHD. We investigated whether diabetes and severe diabetes are CHD risk equivalents. METHODS: At baseline, participants in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study (black and white US adults ≥45 years old recruited in 2003-2007) were categorized as having prevalent CHD only (self-reported or electrocardiogram evidence; n = 3,043), diabetes only (self-reported or elevated glucose; n = 4,012), diabetes and prevalent CHD (n = 1,529), and neither diabetes nor prevalent CHD (n = 17,155). Participants with diabetes using insulin and/or with albuminuria (urinary albumin-to-creatinine ratio ≥30 mg/g) were categorized as having severe diabetes. Participants were followed up through 2011 for CHD events (myocardial infarction or fatal CHD). RESULTS: During a mean follow-up of 5 years, 1,385 CHD events occurred. The hazard ratios of CHD events comparing participants with diabetes only, diabetes, and prevalent CHD and neither diabetes nor prevalent CHD with those with prevalent CHD were 0.65 (95% CI 0.54-0.77), 1.54 (95% CI 1.30-1.83), and 0.41 (95% CI 0.35-0.47), respectively, after adjustment for demographics and risk factors. Compared with participants with prevalent CHD, the hazard ratio of CHD events for participants with severe diabetes was 0.88 (95% CI 0.72-1.09). CONCLUSIONS:Participants with diabetes had lower risk of CHD events than did those with prevalent CHD. However, participants with severe diabetes had similar risk to those with prevalent CHD. Diabetes severity may need consideration when deciding whether diabetes is a CHD risk equivalent.
Authors: Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard Journal: Neuroepidemiology Date: 2005-06-29 Impact factor: 3.282
Authors: H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf Journal: JAMA Date: 2001-07-25 Impact factor: 56.272
Authors: Orlando M Gutiérrez; Yulia A Khodneva; Paul Muntner; Dana V Rizk; William M McClellan; Mary Cushman; David G Warnock; Monika M Safford Journal: JAMA Date: 2013-08-21 Impact factor: 56.272
Authors: Adnan Sultan; Yuting Zheng; Patrick J Trainor; Yong Siow; Alok R Amraotkar; Bradford G Hill; Andrew P DeFilippis Journal: Front Cardiovasc Med Date: 2017-07-31
Authors: Baqiyyah N Conway; Xijing Han; Heather M Munro; Amy L Gross; Xiao-Ou Shu; Margaret K Hargreaves; Wei Zheng; Alvin C Powers; William J Blot Journal: PLoS One Date: 2018-01-11 Impact factor: 3.240
Authors: S A Afanasiev; A A Garganeeva; E A Kuzheleva; A V Andriyanova; D S Kondratieva; S V Popov Journal: J Diabetes Res Date: 2018-07-10 Impact factor: 4.011
Authors: Robert S Rosenson; Lisandro D Colantonio; Greer A Burkholder; Ligong Chen; Paul Muntner Journal: J Am Heart Assoc Date: 2018-12-18 Impact factor: 5.501
Authors: Lisandro D Colantonio; Robert S Rosenson; Luqin Deng; Keri L Monda; Yuling Dai; Michael E Farkouh; Monika M Safford; Kiran Philip; Katherine E Mues; Paul Muntner Journal: J Am Heart Assoc Date: 2019-01-08 Impact factor: 5.501
Authors: Alexandra King; Joanna Bryan Ringel; Monika M Safford; Catherine Riffin; Ronald Adelman; David L Roth; Madeline R Sterling Journal: JAMA Netw Open Date: 2021-02-01
Authors: Demetria Hubbard; Lisandro D Colantonio; Robert S Rosenson; Todd M Brown; Elizabeth A Jackson; Lei Huang; Kate K Orroth; Stephanie Reading; Mark Woodward; Vera Bittner; Orlando M Gutierrez; Monika M Safford; Michael E Farkouh; Paul Muntner Journal: Cardiovasc Diabetol Date: 2021-03-01 Impact factor: 9.951
Authors: M A Salinero-Fort; J Mostaza; C Lahoz; J Cárdenas-Valladolid; J I Vicente-Díez; P Gómez-Campelo; J M de Miguel-Yanes Journal: BMC Geriatr Date: 2022-03-18 Impact factor: 3.921
Authors: Silvio E Inzucchi; Kamlesh Khunti; David H Fitchett; Christoph Wanner; Michaela Mattheus; Jyothis T George; Anne Pernille Ofstad; Bernard Zinman Journal: J Clin Endocrinol Metab Date: 2020-09-01 Impact factor: 5.958
Authors: Lia Alves-Cabratosa; Marc Comas-Cufí; Anna Ponjoan; Maria Garcia-Gil; Ruth Martí-Lluch; Jordi Blanch; Marc Elosua-Bayes; Dídac Parramon; Lourdes Camós; Lidia Guzmán; Rafel Ramos Journal: BMJ Open Diabetes Res Care Date: 2020-03